ELAPEGADEMASE-LVLR for Immunodeficiency: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where ELAPEGADEMASE-LVLR was used for Immunodeficiency.
Most Reported Side Effects for ELAPEGADEMASE-LVLR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Nasopharyngitis | 29 | 11.3% | 0 | 0 |
| Covid-19 | 21 | 8.2% | 0 | 2 |
| Cough | 20 | 7.8% | 0 | 1 |
| Bone marrow transplant | 13 | 5.1% | 0 | 4 |
| Sinusitis | 12 | 4.7% | 0 | 1 |
| Weight decreased | 12 | 4.7% | 0 | 2 |
| Pyrexia | 10 | 3.9% | 0 | 4 |
| Injection site pain | 9 | 3.5% | 0 | 0 |
| Pneumonia | 9 | 3.5% | 1 | 7 |
| Product dose omission | 8 | 3.1% | 0 | 0 |
| Rhinorrhoea | 8 | 3.1% | 0 | 0 |
| Rash | 7 | 2.7% | 0 | 1 |
| Weight increased | 7 | 2.7% | 0 | 0 |
| Diarrhoea | 6 | 2.3% | 0 | 0 |
| Headache | 6 | 2.3% | 0 | 1 |
Other Indications for ELAPEGADEMASE-LVLR
Other Drugs Used for Immunodeficiency
HUMAN IMMUNOGLOBULIN G (2,648)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (404)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (224)
CILGAVIMAB\TIXAGEVIMAB (76)
DUPILUMAB (55)
METRONIDAZOLE (35)
MEROPENEM (28)
VALACYCLOVIR (26)
TOCILIZUMAB (24)
ABATACEPT (23)